Mathew Blackman
Stock Analyst at Stifel
(4.08)
# 423
Out of 4,829 analysts
59
Total ratings
53.49%
Success rate
12.27%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mathew Blackman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INGN Inogen | Maintains: Hold | $10 → $7 | $6.23 | +12.45% | 13 | May 8, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $60 → $31 | $22.98 | +34.90% | 6 | May 1, 2025 | |
| PEN Penumbra | Maintains: Buy | $301 → $318 | $297.32 | +6.96% | 2 | Apr 24, 2025 | |
| CLPT ClearPoint Neuro | Maintains: Buy | $19 → $25 | $14.11 | +77.18% | 3 | Apr 1, 2025 | |
| BBNX Beta Bionics | Initiates: Buy | $25 | $13.95 | +79.21% | 1 | Feb 24, 2025 | |
| PODD Insulet | Maintains: Hold | $245 → $293 | $310.67 | -5.69% | 3 | Feb 21, 2025 | |
| GMED Globus Medical | Maintains: Buy | $92 → $94 | $55.82 | +68.40% | 5 | Feb 21, 2025 | |
| OFIX Orthofix Medical | Upgrades: Buy | $18 → $24 | $12.11 | +98.18% | 5 | Nov 8, 2024 | |
| CERS Cerus | Maintains: Buy | $6 → $3 | $1.29 | +133.46% | 1 | Oct 17, 2024 | |
| DXCM DexCom | Maintains: Buy | $90 → $100 | $84.67 | +18.11% | 11 | Aug 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $16 | $12.21 | +31.04% | 5 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $18 → $11 | $8.58 | +28.28% | 4 | May 10, 2023 |
Inogen
May 8, 2025
Maintains: Hold
Price Target: $10 → $7
Current: $6.23
Upside: +12.45%
Tandem Diabetes Care
May 1, 2025
Maintains: Buy
Price Target: $60 → $31
Current: $22.98
Upside: +34.90%
Penumbra
Apr 24, 2025
Maintains: Buy
Price Target: $301 → $318
Current: $297.32
Upside: +6.96%
ClearPoint Neuro
Apr 1, 2025
Maintains: Buy
Price Target: $19 → $25
Current: $14.11
Upside: +77.18%
Beta Bionics
Feb 24, 2025
Initiates: Buy
Price Target: $25
Current: $13.95
Upside: +79.21%
Insulet
Feb 21, 2025
Maintains: Hold
Price Target: $245 → $293
Current: $310.67
Upside: -5.69%
Globus Medical
Feb 21, 2025
Maintains: Buy
Price Target: $92 → $94
Current: $55.82
Upside: +68.40%
Orthofix Medical
Nov 8, 2024
Upgrades: Buy
Price Target: $18 → $24
Current: $12.11
Upside: +98.18%
Cerus
Oct 17, 2024
Maintains: Buy
Price Target: $6 → $3
Current: $1.29
Upside: +133.46%
DexCom
Aug 23, 2024
Maintains: Buy
Price Target: $90 → $100
Current: $84.67
Upside: +18.11%
Aug 1, 2024
Maintains: Buy
Price Target: $19 → $16
Current: $12.21
Upside: +31.04%
May 10, 2023
Downgrades: Hold
Price Target: $18 → $11
Current: $8.58
Upside: +28.28%